B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Lenograstim

299 PubMed studies analyzed ยท 74 RCTs ยท Evidence Score: 56.3

Research Domains

Lenograstim has been studied across 10 research domains including ๐Ÿ”ฌ Oncology, ๐Ÿ˜ด Sleep, ๐Ÿ›ก๏ธ Immunity, โณ Longevity & Aging, ๐Ÿ’Š Pain. The primary research focus is ๐Ÿ”ฌ Oncology with 37% of studies addressing this area.

Loading evidence profile...

This evidence profile for Lenograstim is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.